Clinical trial · Observational
PET-CT Based Radiotherapy in Esophageal Cancer Patients
Consequences of Positron-Emission-Tomography/Computed Tomography (PET/CT) Based Radiotherapy Treatment Planning for Clinical Outcome in Esophageal Cancer Patients
NCT01156831CI-TRIAL-00016284completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the locoregional control in PET/CT based radiotherapy treatment planning in the treatment of esophageal cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Neoplasms | Esophageal Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Locoregional control
- timeFrame
- 2 years and 5 years
Secondary outcomes (3)
- measure
- Overall Survival
- timeFrame
- 2 years and 5 years
- measure
- Disease Free survival
- timeFrame
- 2 years and 5 years
- measure
- Tumor regression grade
- timeFrame
- At the time of surgery
- description
- Tumor regression grade at time of surgery evaluated by pathologist.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically proven adenocarcinoma or squamous cell carcinoma of the esophagus * Local curable disease able to undergo Chemoradiotherapy. Exclusion Criteria: * Metastasized disease. * Previous or concurrent malignancies.
References
Publications (0)
Data not yet available
No reference posted for this study.